Rexin-G

GENETIC3 trials

Sponsors

Epeius Biotechnologies

Conditions

Breast CancerPancreatic CancerSarcoma

Phase 1

Safety/Efficacy Study of Rexin-G to Treat Pancreatic Cancer

CompletedNCT00504998

Epeius BiotechnologiesPancreatic Cancer

Start: 2007-07-31End: 2011-06-30Updated: 2011-06-10

Safety and Efficacy Study Using Rexin-G for Breast Cancer

CompletedNCT00505271

Epeius BiotechnologiesBreast Cancer

Start: 2007-07-31End: 2011-06-30Updated: 2011-06-10

Safety and Efficacy Study Using Rexin-G for Sarcoma

CompletedNCT00505713

Epeius BiotechnologiesSarcoma

Start: 2007-07-31End: 2011-06-30Updated: 2011-06-10